THE US VACCINES

Vaccine mRNA-1273 - Moderna Therapeutics

The biotechnology company Moderna Therapeutics together with the NIH (National Institute of Allergy and Infectious Diseases), develop a vaccine based on nRNA-1273, which is a research product of

The vaccine started the experimental test against the coronavirus in humans in mid-March.

Bill Gates' shot

The development funded by Bill and Melinda Gates is already beginning to be tested on humans. The so-called INO-4800 is being developed by Inovio Pharmaceuticals. The company expects the results on the immune responses of the 40 volunteers.

Also called the Bill Gates Vaccine, it is made up of a genetic structure that, when inserted into a patient, seeks for its cells to produce a specific antibody that manages to fight a particular infection.

CHINESE DEVELOPMENTS

AD5-nCoV vaccine - CanSino Biologics

CanSino Biologics, a Chinese laboratory advances to the second phase of testing of the coronavirus vaccine. The AD5-nCoV vaccine has already successfully completed the first stage of testing.
The Biotechnology Institute of the Academy of Military Medical Sciences also participates in this second phase after preliminary data from the first stage indicated that it was safe to proceed.

LV-SMENP-DC vaccine from Shenzhen Genoimmune Medical Institute

The LV-SMENP-DC vaccine from the Shenzhen Genoimmune Medical Institute (China) is focused on the use of dendritic cells modified with lentiviral vectors and has already received approval from the Chinese authorities for clinical trials.

Inactivated virus vaccine from Wuhan Biological Products Institute

Wuhan, where the pandemic started, is also fighting for the development of the vaccine to stop the pandemic, and the Wuhan Biological Products Institute, China developed an inactivated vaccine, that is, consisting of microorganisms that have been killed through processes. physical or chemical. It is produced jointly with the Sinopharm company.

The project will test the vaccine on 1,396 volunteers recruited in Henan province in its first two phases, which are expected to last until November 10, 2021.

THE VACCINE OF THE UNITED KINGDOM

ChAdOx1, the vaccine that could be ready in September

Sarah Gilbert, a professor of vaccinology at the University of Oxford, told the London newspaper The Times that a vaccine developed by the University could be ready in September 2002.

“That is possible, if everything goes perfectly. We have to go for it. No one can give guarantees, no one can promise that it will work and no one can give a definitive date, but we have to do everything we can as fast as we can, "said the scientist in an interview with the British newspaper.